These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16886193)

  • 1. Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration.
    Vega E; Egea MA; Valls O; Espina M; García ML
    J Pharm Sci; 2006 Nov; 95(11):2393-405. PubMed ID: 16886193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
    Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
    J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.
    Ramos Yacasi GR; García López ML; Espina García M; Parra Coca A; Calpena Campmany AC
    Int J Nanomedicine; 2016; 11():4093-106. PubMed ID: 27601897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
    Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
    Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
    Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
    Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
    Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
    Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
    El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
    Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.
    Vega E; Gamisans F; García ML; Chauvet A; Lacoulonche F; Egea MA
    J Pharm Sci; 2008 Dec; 97(12):5306-17. PubMed ID: 18425815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil].
    Shen JQ; Gan Y; Gan L; Zhu CL; Zhu JB
    Yao Xue Xue Bao; 2010 Jan; 45(1):120-5. PubMed ID: 21351461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect.
    Shen J; Gan L; Zhu C; Zhang X; Dong Y; Jiang M; Zhu J; Gan Y
    Int J Pharm; 2011 Jun; 412(1-2):115-22. PubMed ID: 21440613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels.
    Gonzalez-Mira E; Nikolić S; Calpena AC; Egea MA; Souto EB; García ML
    J Pharm Sci; 2012 Feb; 101(2):707-25. PubMed ID: 22012873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
    Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
    Radwan MA; Aboul-Enein HY
    Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.